Research Summary
Dr. Dy has extensively investigated quality of care, safety and decision-making, particularly in patients with cancer and other serious and terminal illnesses. Her research has included systematic literature reviews, primary qualitative and quantitative data collection, analyses of secondary databases and quality measurement improvement. She is particularly interested in improving health systems and services to increase the appropriateness of technology and medication use, as well as in end-of-life health care policy, especially with quality measurement.
Selected Publications
View all on PubMed
Winters BD, Bharmal A, Wilson RF, Zhang A, Engineer L, Defoe D, Bass EB, Dy S, Pronovost PJ. “Validity of the agency for health care research and quality patient safety indicators and the centers for Medicare and Medicaid hospital-acquired conditions: a systematic review and meta-analysis.” Med Care. 2016 Dec;54(12):1105-1111.
Waldfogel JM, Battle DJ, Rosen M, Knight L, Saiki CB, Nesbit SA, Cooper RS, Browner IS, Hoofring LH, Billing LS, Dy SM. “Team leadership and cancer end-of-life decision making.” J Oncol Pract. 2016 Nov;12(11):1135-1140.
Lee JL, Beach MC, Berger ZD, Pfoh ER, Gallo J, Dy SM, Wu AW. “A qualitative exploration of favorite patients in primary care.” Patient Educ Couns. 2016 Nov;99(11):1888-1893. doi: 10.1016/j.pec.2016.06.023.
Lashoher A, Schneider EB, Juillard C, Stevens K, Colantuoni E, Berry WR, Bloem C, Chadbunchachai W, Dharap S, Dy SM, Dziekan G, Gruen RL, Henry JA, Huwer C, Joshipura M, Kelley E, Krug E, Kumar V, Kyamanywa P, Mefire AC, Musafir M, Nathens AB, Ngendahayo E, Nguyen TS, Roy N, Pronovost PJ, Khan IQ, Razzak JA, Rubiano AM, Turner JA, Varghese M, Zakirova R, Mock C. “Implementation of the World Health Organization Trauma Care Checklist Program in 11 centers across multiple economic strata: effect on care process measures.” World J Surg. 2016 Oct 31. [Epub ahead of print]
Waldfogel JM, Nesbit S, Cohen SP, Dy SM. “Successful treatment of opioid-refractory cancer pain with short-course, low-dose ketamine.” J Pain Palliat Care Pharmacother. 2016 Oct 18:1-4. [Epub ahead of print].
